Acumen Pharmaceuticals, (ABOS) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
81
Total Shares Held
42.49M
Total Value
$73.10M
Institutional Holding %
70.73%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
Institution | Shares | Ownership % | Value |
---|---|---|---|
RA | 14.93M | 24.85% | $25.68M |
SANDS VENTURES | 3.42M | 5.69% | $5.88M |
FRANKLIN RESOURCES | 3.27M | 5.45% | $5.63M |
BlackRock | 2.37M | 3.95% | $4.08M |
FMR | 2.02M | 3.37% | $3.48M |
VANGUARD | 1.94M | 3.23% | $3.34M |
ROCK SPRINGS | 1.84M | 3.06% | $3.16M |
KNOLLWOODY | 1.63M | 2.71% | $2.80M |
MILLENNIUM | 1.34M | 2.24% | $2.31M |
ALYESKA | 939.60K | 1.56% | $1.62M |
Recent Insider Trading
Insider | Title | Transaction | Shares | Value | Date |
---|---|---|---|---|---|
Zuga Matt | Cfo & Chief Business Officer | S-Sale | 4.36K | $6.99K | Jan 21, 2025 |
Zuga Matt | Cfo & Chief Business Officer | S-Sale | 28.90K | $49.63K | Jan 23, 2025 |
Oconnell Daniel Joseph | Director, Chief Executive Officer | S-Sale | 12.62K | $20.10K | Jan 21, 2025 |
Meisner Derek M | Chief Legal Officer & Corp Sec | S-Sale | 3.42K | $5.43K | Jan 21, 2025 |
Barton Russell | Chief Operating Officer | S-Sale | 2.91K | $4.69K | Jan 21, 2025 |
Siemers Eric | Chief Medical Officer | S-Sale | 3.22K | $5.12K | Jan 21, 2025 |
Oconnell Daniel Joseph | Director, Chief Executive Officer | A-Award | 225.40K | $- | Jan 07, 2025 |
Oconnell Daniel Joseph | Director, Chief Executive Officer | S-Sale | 47.78K | $87.87K | Jan 03, 2025 |
Oconnell Daniel Joseph | Director, Chief Executive Officer | A-Award | 338.00K | $618.54K | Jan 07, 2025 |
Schacterle Amy | Chief Regulatory Officer | A-Award | 13.20K | $24.42K | Jan 06, 2025 |
Recent Position Changes
Institution | Shares Changed | % Change | Date |
---|---|---|---|
JPMorgan CHASE | +874.84K | +1387.18% | Feb 12, 2025 |
MILLENNIUM | -490.01K | -26.71% | Feb 14, 2025 |
ROCK SPRINGS | -461.14K | -20.05% | Feb 14, 2025 |
JANE STREET | -456.86K | -93.70% | Feb 14, 2025 |
FRANKLIN RESOURCES | -275.44K | -7.76% | Feb 12, 2025 |
UBS | +118.74K | +521.92% | Feb 14, 2025 |
ADAR1 | +94.29K | +100.00% | Feb 13, 2025 |
GROUP ONE TRADING | -93.74K | -76.47% | Feb 14, 2025 |
PATHSTONE | +89.56K | +17.31% | Feb 14, 2025 |
DEUTSCHE BANK\ | +79.94K | +468.72% | Feb 14, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 23, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 23, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 23, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 23, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 23, 2025
144
Form 144 - Report of proposed sale of securities
Jan 23, 2025
144
Form 144 - Report of proposed sale of securities
Jan 21, 2025
144
Form 144 - Report of proposed sale of securities
Jan 21, 2025
144
Form 144 - Report of proposed sale of securities
Jan 21, 2025
144
Form 144 - Report of proposed sale of securities
Jan 21, 2025
144
Form 144 - Report of proposed sale of securities
Jan 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 07, 2025
144
Form 144 - Report of proposed sale of securities
Jan 03, 2025
144
Form 144 - Report of proposed sale of securities
Jan 03, 2025
Related Metrics
Explore detailed financial metrics and analysis for ABOS.